Correlation Between Alanine Aminotransferase and Left Ventricular Mass in Patients with Non-Alcoholic Fatty Liver Disease
Background: Non-alcoholic fatty liver disease (NAFLD) is considered a risk factor for chronic kidney disease, endocrinopathies, cardiovascular disease (CVD), cerebrovascular disease and osteoporosis. Many prospective follow-up studies demonstrated cardiovascular mortality as an important cause of death in these patients. However, the exact relationship between ALT and CVD especially LVH is undetermined.
Objective: The objective of this study was to determine the correlation between raised ALT levels and left ventricular mass (LVM) in NAFLD patients.
Methods: In this cross sectional analytical study, 115 patients (both male and female) were selected through non-probability purposive sampling technique after meeting inclusion and exclusion criteria. These patients, aged 20-60 years, were diagnosed cases of NAFLD with transaminitis (ALT ≥40 unit/L). Venous samples were collected for ALT, viral serology and fasting lipid profile. All the patients underwent ultrasound abdomen and echocardiography for LVM.
Results: Mean age of patients was 44.63±1.03 while gender distribution showed 55(47.8%) male and 60(52.2%) female patients with a mean body mass index (BMI) of 26.75±5.048. Mean ALT level was 56.68±9.08 and mean LVM was 190.60±14.23 grams. Correlation coefficient for ALT and LVM was 0.571 which showed moderate correlation between these two parameters. A positive moderate correlation existed between ALT and LVM after stratifying the data according to age, gender and BMI.
Conclusion: Elevated ALT levels in NAFLD patients can serve as a screening tool for cardiovascular risk assessment. Whether there is a temporal relationship between transaminitis and an increased risk of cardiovascular events needs further statistical evidence.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments firstname.lastname@example.org